Mr. Habil Khorakiwala
Immediate Past President

Mr. Habil Khorakiwala, is the Chairman of Wockhardt Limited one of the leading Indian Pharmaceutical and Healthcare companies in India.

Mr. Khorakiwala holds a Masters Degree in Pharmaceutical Science from the Purdue University, USA and is an alumni of the Harvard Business School, USA.

Under the dynamic stewardship of Mr. Khorakiwala, Wockhardt has grown to be one of the top pharmaceutical companies in India employing more than 4500 people, spread over 9 plants and 12 offices worldwide. Wockhardt is among India's largest research-oriented and globally competitive pharmaceutical companies. Wockhardt's presence covers more than 90 countries across the globe. Today, Wockhardt has businesses ranging from the manufacture and marketing of pharmaceutical formulations, bulk drugs, vaccines, medical nutrition and animal health products and hospitals. A front-runner in biotechnology, Wockhardt has an active multi-disciplinary R&D programme employing over 400 scientists. Its new drug discovery programme, started about four years ago, has yielded lead molecules, one of which is under Human (Phase-I) clinical trials. Wockhardt recently launched India's first recombinant human insulin, making India the first Asian country to develop, manufacture and market the product. It is the world's 4th producer of Insulin. The President of India Dr. APJ Abdul Kalam recently inaugurated the Wockhardt Biotech Park, India's largest biopharmaceutical complex with six dedicated manufacturing plants at Aurangabad. The Rs 200-crore state-of-the-art biopharmaceutical complex, spread over 3 lakh square feet, has capacities to cater to 10% to 15% of the global demand for major biopharmaceuticals.

Wockhardt has made various successful acquisition - Most recent being the acquisition of the German company Esparma. With its acquisition of the UK Company C P Pharmaceuticals with 450 people and a sales turnover of pound 34 Million (roughly Rs 256 crores) Wockhardt becomes the No. 1 Indian Pharmaceutical Company and one of the Top 10 Generic Pharmaceutical Companies in UK. Wockhardt has also alliances with Companies in many other countries.

For his contribution to Indian business and industry, Mr Khorakiwala has received many prestigious awards.

• The Ernst & Young Entrepreneur of the Year Award for 2004 in the `Healthcare and Life Sciences' category.
• Award for `Excellence as Top CEO' for the year 2002 from the Institute of Marketing & Management (IMM), New Delhi, at the 29th World Marketing Congress.
• Awarded the Life Time Achievement Award by the International Medical Integration Council
• Awarded the Giants International Award 2003 for Business and Industry

Mr. Khorakiwala has been a Non-Official Director on the Board of Directors of Union Bank of India; and is a Member of the Board of Governors, Centre for Organisation Development at Hyderabad